Matches in SemOpenAlex for { <https://semopenalex.org/work/W1974043145> ?p ?o ?g. }
- W1974043145 endingPage "610" @default.
- W1974043145 startingPage "599" @default.
- W1974043145 abstract "The aim of this study was to conduct an initial evaluation of the efficacy of atomoxetine for attention-deficit/hyperactivity disorder (ADHD) symptoms in children with pervasive developmental disorders (PDDs).Children with PDDs and a nonverbal IQ of >or=70 received atomoxetine (target dose 1.2-1.4 mg/kg/day) during the course of an 8-week, open-label, prospective study. Standardized assessments of efficacy and tolerability were collected at regular intervals during the trial.Sixteen children and adolescents (mean age 7.7 +/- 2.2 years, age range 6-14 years) with autistic disorder (n = 7), Asperger's disorder (n = 7), or PDD not otherwise specified (n = 2) received atomoxetine (mean dose 1.2 +/- 0.3 mg/kg/day). Twelve participants (75%) were rated as much or very much improved on the Clinical Global Impressions-Improvement scale. The most significant improvement was seen in the area of ADHD symptoms as measured by the SNAP-IV and Aberrant Behavior Checklist (effect size = 1.0-1.9). Improvements of lesser magnitude (effect size = 0.4-1.1) were seen in irritability, social withdrawal, stereotypy, and repetitive speech. There were no significant changes on the Conners' Continuous Performance Test. Atomoxetine was well tolerated with the exception of 2 participants (13 %) who stopped medication due to irritability. Weight decreased by a mean of 0.8 kg during the 8-week trial.Placebo-controlled studies are indicated to determine atomoxetine's efficacy for ADHD symptoms in PDDs." @default.
- W1974043145 created "2016-06-24" @default.
- W1974043145 creator A5010641013 @default.
- W1974043145 creator A5019555383 @default.
- W1974043145 creator A5020947008 @default.
- W1974043145 creator A5030232670 @default.
- W1974043145 creator A5049538258 @default.
- W1974043145 creator A5053463157 @default.
- W1974043145 date "2006-10-01" @default.
- W1974043145 modified "2023-10-02" @default.
- W1974043145 title "Open-Label Atomoxetine for Attention-Deficit/ Hyperactivity Disorder Symptoms Associated with High-Functioning Pervasive Developmental Disorders" @default.
- W1974043145 cites W1498586118 @default.
- W1974043145 cites W1588132147 @default.
- W1974043145 cites W1968430210 @default.
- W1974043145 cites W1980309199 @default.
- W1974043145 cites W2007445647 @default.
- W1974043145 cites W2015392618 @default.
- W1974043145 cites W2038535375 @default.
- W1974043145 cites W2053295943 @default.
- W1974043145 cites W2054797832 @default.
- W1974043145 cites W2066817339 @default.
- W1974043145 cites W2071090844 @default.
- W1974043145 cites W2079773266 @default.
- W1974043145 cites W2083338868 @default.
- W1974043145 cites W2085347131 @default.
- W1974043145 cites W2118648637 @default.
- W1974043145 cites W2122518346 @default.
- W1974043145 cites W2144446993 @default.
- W1974043145 cites W2147341063 @default.
- W1974043145 cites W2155856343 @default.
- W1974043145 cites W2602801922 @default.
- W1974043145 cites W4229960595 @default.
- W1974043145 doi "https://doi.org/10.1089/cap.2006.16.599" @default.
- W1974043145 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17069548" @default.
- W1974043145 hasPublicationYear "2006" @default.
- W1974043145 type Work @default.
- W1974043145 sameAs 1974043145 @default.
- W1974043145 citedByCount "106" @default.
- W1974043145 countsByYear W19740431452012 @default.
- W1974043145 countsByYear W19740431452013 @default.
- W1974043145 countsByYear W19740431452014 @default.
- W1974043145 countsByYear W19740431452015 @default.
- W1974043145 countsByYear W19740431452016 @default.
- W1974043145 countsByYear W19740431452017 @default.
- W1974043145 countsByYear W19740431452018 @default.
- W1974043145 countsByYear W19740431452019 @default.
- W1974043145 countsByYear W19740431452021 @default.
- W1974043145 countsByYear W19740431452022 @default.
- W1974043145 countsByYear W19740431452023 @default.
- W1974043145 crossrefType "journal-article" @default.
- W1974043145 hasAuthorship W1974043145A5010641013 @default.
- W1974043145 hasAuthorship W1974043145A5019555383 @default.
- W1974043145 hasAuthorship W1974043145A5020947008 @default.
- W1974043145 hasAuthorship W1974043145A5030232670 @default.
- W1974043145 hasAuthorship W1974043145A5049538258 @default.
- W1974043145 hasAuthorship W1974043145A5053463157 @default.
- W1974043145 hasConcept C118552586 @default.
- W1974043145 hasConcept C126322002 @default.
- W1974043145 hasConcept C142724271 @default.
- W1974043145 hasConcept C15744967 @default.
- W1974043145 hasConcept C187212893 @default.
- W1974043145 hasConcept C197934379 @default.
- W1974043145 hasConcept C204787440 @default.
- W1974043145 hasConcept C27081682 @default.
- W1974043145 hasConcept C2777112843 @default.
- W1974043145 hasConcept C2778375690 @default.
- W1974043145 hasConcept C2778781522 @default.
- W1974043145 hasConcept C2780783007 @default.
- W1974043145 hasConcept C2780820931 @default.
- W1974043145 hasConcept C2909253567 @default.
- W1974043145 hasConcept C558461103 @default.
- W1974043145 hasConcept C70410870 @default.
- W1974043145 hasConcept C71924100 @default.
- W1974043145 hasConceptScore W1974043145C118552586 @default.
- W1974043145 hasConceptScore W1974043145C126322002 @default.
- W1974043145 hasConceptScore W1974043145C142724271 @default.
- W1974043145 hasConceptScore W1974043145C15744967 @default.
- W1974043145 hasConceptScore W1974043145C187212893 @default.
- W1974043145 hasConceptScore W1974043145C197934379 @default.
- W1974043145 hasConceptScore W1974043145C204787440 @default.
- W1974043145 hasConceptScore W1974043145C27081682 @default.
- W1974043145 hasConceptScore W1974043145C2777112843 @default.
- W1974043145 hasConceptScore W1974043145C2778375690 @default.
- W1974043145 hasConceptScore W1974043145C2778781522 @default.
- W1974043145 hasConceptScore W1974043145C2780783007 @default.
- W1974043145 hasConceptScore W1974043145C2780820931 @default.
- W1974043145 hasConceptScore W1974043145C2909253567 @default.
- W1974043145 hasConceptScore W1974043145C558461103 @default.
- W1974043145 hasConceptScore W1974043145C70410870 @default.
- W1974043145 hasConceptScore W1974043145C71924100 @default.
- W1974043145 hasIssue "5" @default.
- W1974043145 hasLocation W19740431451 @default.
- W1974043145 hasLocation W19740431452 @default.
- W1974043145 hasOpenAccess W1974043145 @default.
- W1974043145 hasPrimaryLocation W19740431451 @default.
- W1974043145 hasRelatedWork W1969779240 @default.
- W1974043145 hasRelatedWork W1998328704 @default.
- W1974043145 hasRelatedWork W2011034909 @default.